[Epigenetics in hematological disorders].
Yusuke
Y
Furukawa
D000970:Antineoplastic Agents; D001374:Azacitidine; D019175:DNA Methylation; D047630:Depsipeptides; D015195:Drug Design; D004791:Enzyme Inhibitors; D044127:Epigenesis, Genetic; D015972:Gene Expression Regulation, Neoplastic; D019337:Hematologic Neoplasms / Q000188:drug therapy / Q000235:genetics*; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000502:physiology; D006657:Histones; D006801:Humans; D006877:Hydroxamic Acids; D009154:Mutation; D009707:Nucleosomes / Q000235:genetics; D014158:Transcription, Genetic; D000077337:Vorinostat
D000970:Antineoplastic Agents; D047630:Depsipeptides; D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors; D006657:Histones; D006877:Hydroxamic Acids; D009707:Nucleosomes; D000077337:Vorinostat; C087123:romidepsin; D006655:Histone Deacetylases; D001374:Azacitidine